A5077669248- Transplantation: Methods and Outcomes
- Airway Management and Intubation Techniques
- Hepatitis C virus research
- Tracheal and airway disorders
- Renal Transplantation Outcomes and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- SARS-CoV-2 and COVID-19 Research
- Anesthesia and Pain Management
- Congenital Diaphragmatic Hernia Studies
- Tumors and Oncological Cases
- Autoimmune and Inflammatory Disorders Research
- Organ Transplantation Techniques and Outcomes
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Opioid Use Disorder Treatment
- Adolescent and Pediatric Healthcare
- HIV/AIDS drug development and treatment
- Antifungal resistance and susceptibility
- COVID-19 epidemiological studies
- Respiratory Support and Mechanisms
- Polyomavirus and related diseases
- Hepatitis B Virus Studies
- Nausea and vomiting management
- COVID-19 Clinical Research Studies
- Respiratory viral infections research
Miami Transplant Institute
2020-2022
NYU Langone Health
2020-2021
New York University
2020-2021
Columbia University Irving Medical Center
2020
Anna Needs Neuroblastoma Answers
2018
BackgroundCoronavirus 2019 (COVID-19) is a worldwide pandemic, with many patients requiring prolonged mechanical ventilation. Tracheostomy not recommended by current guidelines as it considered superspreading event owing to aerosolization that unduly risks health care workers.MethodsPatients severe COVID-19 who were on ventilation for 5 days or longer evaluated percutaneous dilational tracheostomy. We developed novel tracheostomy technique placed the bronchoscope alongside endotracheal tube,...
Decision-making in the timing of tracheostomy patients with coronavirus disease 2019 (COVID-19) has centered on intersection long-standing debates benefits early vs late tracheostomy, assumptions about timelines infectivity novel coronavirus, and concern over risk to surgeons performing tracheostomy. Multiple consensus guidelines recommend avoiding or delaying without evidence indicate anticipated improvement outcomes as a result.To assess from airway management COVID-19 requiring mechanical...
To assess the impact of percutaneous dilational tracheostomy in coronavirus disease 2019 patients requiring mechanical ventilation and risk for healthcare providers.Prospective cohort study; were enrolled between March 11, April 29, 2020. The date final follow-up was July 30, We used a propensity score matching approach to compare outcomes. Study outcomes formulated before data collection analysis.Critical care units at two large metropolitan hospitals New York City.Five-hundred forty-one...
Opioid analgesics are commonly used post-lung transplant, but have many side effects and associated with worse outcomes. We conducted a retrospective review of all lung transplant recipients who were treated multimodal opioid-sparing pain protocol. The use liposomal bupivacaine intercostal nerve block was variable due to hospital restrictions. primary objective describe opioid requirements patient-reported scores early assess the impact intraoperative block. 64 our utilization decreased mean...
Abstract We conducted a retrospective review of thoracic transplant recipients (22 heart and 16 lung recipients) prospectively enrolled in single‐center observational study HCV NAT+ organ transplantation NAT− recipients. All were treated with 8 weeks glecaprevir‐pibrentasvir (GP) for viremia addition to standard triple immunosuppression post‐transplant. Thoracic organs used as control (24 22 recipients). Our primary outcome was assess the effect GP on tacrolimus dose requirements. Secondary...
When the novel coronavirus began spreading rapidly in New York City, pulmonary transplant patients were considered as one of highest medically vulnerable patient populations. It became a priority to devise plan safely provide quality care patients, with minimal exposure outside world possible. Utilizing telemedicine system that was already place, program able be expanded include all our 77 transplanted who would track their vital signs and spirometry at home twice daily, while also having...
Purpose: Solid organ transplant recipients are at high risk of morbidity and mortality from coronavirus disease 2019 (COVID-19) with rates as 30% reported in the early pandemic period. COVID-19 vaccine efficacy immunosuppressed population is lower than general population. Early studies suggest that monoclonal antibody (MAB) treatment against SARS-CoV-S spike protein may decrease hospitalizations emergency department (ED) visits. Herein, we report our single center experience use MAB for...
Mitchell, Oscar; Anderson, Christopher; Sureau, Kimberly; Horowitz, James; Piper, Greta; Nunnally, Mark; Smith, Deane Author Information